SCHEMBL389461

SCHEMBL389461

O=C1CCc2c(O)cccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.56
MAOB P27338 2/20 0.51
CYP19A1 P11511 2/20 0.47
MAOA P21397 2/20 0.45
ALDH1A1 P00352 4/20 0.43
HPGD P15428 3/20 0.43
MAPT P10636 2/20 0.43
ALOX15 P16050 2/20 0.43
MAPK1 P28482 2/20 0.43
HSD17B10 Q99714 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GAA P10253 1/20 0.43
BCL2L1 Q07817 1/20 0.42
BAD Q92934 1/20 0.42
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29392687 1.00 PARP1 (0.56) PARP1MAOBCYP19A1MAOAALDH1A1
SCHEMBL388480 0.88 PARP1 (0.53) PARP1MAOBCYP19A1MAOAALDH1A1
SCHEMBL14120724 0.88 BCL2L1 (0.53) PARP1MAOBCYP19A1MAOAALDH1A1
SCHEMBL21772776 0.86 PARP1 (0.51) PARP1MAOBCYP19A1MAOAALDH1A1
SCHEMBL5793477 0.78 MAOA (0.56) PARP1MAOBMAOAALDH1A1HPGD
SCHEMBL5541367 0.76 ALDH1A1 (0.41) PARP1MAOBMAOAALDH1A1HPGD
SCHEMBL31032281 0.75 ALDH1A1 (0.47) ALDH1A1MAPTALOX15HSD17B10LMNA
SCHEMBL569778 0.75 ALDH1A1 (0.47) ALDH1A1MAPTALOX15HSD17B10LMNA
SCHEMBL17613901 0.75 ALDH1A1 (0.42) PARP1MAOBMAOAALDH1A1HPGD
SCHEMBL1658784 0.74 PARP1 (0.47) PARP1MAOBCYP19A1MAOAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114920635-B Preparation method of 4-hydroxy-1-indenone 郑州原理医药研究院有限公司 2023-05-12 CN claimed
CN-113248356-B Industrial production method of 4-hydroxy-1-indanone 宣城菁科生物科技有限公司 2023-04-04 CN claimed
CN-114920635-A Preparation method of 4-hydroxy-1-indanone 郑州原理生物科技有限公司 2022-08-19 CN claimed
CN-113248356-A Industrial production method of 4-hydroxy-1-indanone 宣城菁科生物科技有限公司 2021-08-13 CN claimed
CN-108101024-B Method for preparing carbon nano tube by mixed gas source 江苏天奈科技股份有限公司 2020-07-10 CN claimed
WO-2009071799-A1 PROCESS FOR THE SYNTHESIS OF 4-BENZOFURANCARBOXYLIC ACID ZACH SYSTEM (FR) 2009-06-11 WO claimed
US-20090131688-A1 METHOD FOR THE SYNTHESIS OF 4-BENZOFURAN-CARBOXYLIC ACID ZACH SYSTEM (FR) 2009-05-21 US claimed
US-5618982-A SIMPLE INDUSTRIAL PROCESS OF CATALYZING IN PRESENCE OF METALLIC PHOSPHATES RHONE-POULENC CHIMIE (FR) 1997-04-08 US claimed
JP-56108723-A None JP disclosed
US-12590062-B2 PD-1/PD-L1 inhibitors GILEAD SCIENCES, INC. (US) 2026-03-31 US disclosed
US-20250360486-A1 Biorefining Method LICELLA PTY LTD (AU) 2025-11-27 US disclosed
EP-4619386-A1 ARYL THIOETHERS AS HIF-2ALPHA INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-09-24 EP disclosed
US-12421193-B2 GPR52 modulators and methods of use NEUROCRINE BIOSCIENCES, INC. (US) 2025-09-23 US disclosed
US-12409437-B2 Biorefining method LICELLA PTY LTD (AU) 2025-09-09 US disclosed
US-4322414-A MITICIDES; APHIDICIDES; LARVICIDES VELSICOL CHEMICAL CORPORATION (US) 1982-03-30 US disclosed
EP-0043971-A1 Indanoneoxyalkylpiperazine derivatives, the preparation thereof and pharmaceutical compositions containing the same BASF Aktiengesellschaft (DE) 1982-01-20 EP disclosed
JP-S56108723-A PREPARATION OF INDENE DERIVATIVE IWAKI SEIYAKU KK 1981-08-28 JP disclosed
US-4109088-A ANTIDEPRESSANTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1978-08-22 US disclosed
US-4076726-A Amidino-hydrazone derivatives AKZONA INCORPORATED (US) 1978-02-28 US disclosed
US-4028380-A Hydrazino-imidazole derivatives AKZONA INCORPORATED (US) 1977-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131688-A1 METHOD FOR THE SYNTHESIS OF 4-BENZOFURAN-CARBOXYLIC ACID COASY, HSD17B12, ALDH18A1 PARP1 1500/4885MAOB 335/4885CYP19A1 7/4885
US-12590062-B2 PD-1/PD-L1 inhibitors CD274, PDCD1LG2, PDCD1 PARP1 401/4885MAOB 1633/4885CYP19A1 1342/4885
US-12421193-B2 GPR52 modulators and methods of use GPR52, GPR68, GPR35 PARP1 4171/4885MAOB 947/4885CYP19A1 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.